Cardioloxía
Servicio
Federico
Guerra
Publicacións nas que colabora con Federico Guerra (16)
2022
-
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136
-
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry
Journal of the American Heart Association, Vol. 11, Núm. 13
2021
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966
2019
-
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry
JAMA Cardiology, Vol. 4, Núm. 6, pp. 526-548
-
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry
Journal of the American Heart Association, Vol. 8, Núm. 3
-
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
American Heart Journal, Vol. 213, pp. 35-46
-
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry
Clinical Cardiology, Vol. 42, Núm. 5, pp. 553-560
2018
-
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry
European Heart Journal, Vol. 39, Núm. 6, pp. 464-473
-
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation
PLoS ONE, Vol. 13, Núm. 1
-
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835
2017
-
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
Heart, Vol. 103, Núm. 4, pp. 307-314
-
Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry
BMJ Open, Vol. 7, Núm. 3
-
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
BMJ Open, Vol. 7, Núm. 12
2016
-
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists
British Journal of Haematology, Vol. 174, Núm. 4, pp. 610-623
-
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry
PLoS ONE, Vol. 11, Núm. 10
-
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
European Heart Journal, Vol. 37, Núm. 38, pp. 2882-2889